BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2968 related articles for article (PubMed ID: 6891842)

  • 1. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.
    Collen D; Rijken DC; Van Damme J; Billiau A
    Thromb Haemost; 1982 Dec; 48(3):294-6. PubMed ID: 6891842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
    Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
    Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
    Einarsson M; Brandt J; Kaplan L
    Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tissue plasminogen activator].
    Matsuo O
    Rinsho Ketsueki; 1984 Jul; 25(7):1004-10. PubMed ID: 6542154
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
    Rijken DC; Juhan-Vague I; de Cock F; Collen D
    J Lab Clin Med; 1983 Feb; 101(2):274-84. PubMed ID: 6681623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of plasminogen activator in a melanoma cell line.
    Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
    Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.
    Kruithof EK; Schleuning WD; Bachmann F
    Biochem J; 1985 Mar; 226(3):631-6. PubMed ID: 4039134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a melanoma cell plasminogen activator.
    Wallén P; Pohl G; Bergsdorf N; Rånby M; Ny T; Jörnvall H
    Eur J Biochem; 1983 May; 132(3):681-6. PubMed ID: 6682760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
    Rijken DC; Collen D
    J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extrinsic plasminogen activator: molecular properties and potential value as a new thrombolytic agent].
    Collen D
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):295-305. PubMed ID: 6223460
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
    Heussen C; Joubert F; Dowdle EB
    J Biol Chem; 1984 Oct; 259(19):11635-8. PubMed ID: 6541221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of plasminogen activators by cultured bovine endothelial cells: partial purification, characterization and evidence for multiple forms.
    Laug WE
    Thromb Haemost; 1981 Jun; 45(3):219-24. PubMed ID: 7197062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.
    Kacian DL; Harvey RC
    Arch Biochem Biophys; 1985 Jan; 236(1):354-69. PubMed ID: 2981508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability of tissue plasminogen activator (t-PA).
    Gaffney PJ; Templeman J; Curtis AD; Campbell PJ
    Thromb Haemost; 1983 Oct; 50(3):650-1. PubMed ID: 6685926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of tissue plasminogen activator by an enzyme-immunoassay method.
    Matsuo O; Kato K; Matsuo C; Matsuo T
    Anal Biochem; 1983 Nov; 135(1):58-63. PubMed ID: 6367540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 149.